copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Home | Harrow, Inc. Harrow is redefining the standard of care in eyecare with a portfolio of trusted, high-value pharmaceutical solutions that deliver proven safety, efficacy, and affordability
Harrow Announces First-Quarter 2025 Financial Results Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market
SEC Filings | Harrow, Inc. The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
Corporate Presentation November 2025 - harrow. com Harrow was founded to advance the standard of eye care and deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes
Careers | Harrow, Inc. At Harrow, we’re always interested in connecting with talented, purpose-driven, and mission-minded individuals who share our passion for advancing eye health and improving patients’ lives
Compliance with California Health Safety Code - harrow. com Eye, LLC (“Harrow”) has established a CCP in accordance with the OIG Guidance and has policies in place to foster compliance with the PhRMA Code For purposes of compliance with the requirements of the California Compliance Law and as part of the CPP, Harrow has established a specific annual aggregate dollar limit of $2,000 on gifts
Quarterly Results | Harrow, Inc. The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
www. harrow. com harrow health inc-2 harrow health inc-1 harrow health inc Harrow Health INC 2,145,767 shares of common stock available for award under the Company’s 2017 Incentive Stock and Awards Plan (the “Plan) as of March 31, 2023;